Related Experiment Video
Updated: Jan 7, 2026
Focused Ion Beam Fabrication of LiPON-based Solid-state Lithium-ion Nanobatteries for In Situ Testing
Published on: March 7, 2018
Minibeam-pLATTICE: A novel proton LATTICE modality using minibeams
Nimita Shinde1, Weijie Zhang2, Yuting Lin1
1Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Background:
LATTICE, a form of spatially fractionated radiation therapy (SFRT) that delivers high-dose peaks and low-dose valleys within the target volume, has been clinically utilized for treating bulky tumors. However, its application to small-to-medium-sized target volumes remains challenging due to beam size limitations.
Purpose:
To address the challenge of applying LATTICE radiation therapy to small-to-medium-sized targets, this work proposes a novel proton LATTICE (pLATTICE) modality using minibeams, namely minibeam-pLATTICE, that can extend the LATTICE approach for small-to-medium target volumes.
Methods:
Three minibeam-pLATTICE methods are introduced. (1) M0: a fixed minibeam aperture orientation (e.g., 0°) for all beam angles; (2) M1: alternated minibeam aperture orientations (e.g., between 0° and 90°), for consecutive beam angles; (3) M2: multiple minibeam aperture orientations (e.g., 0° and 90°) for each beam angle. The purpose of M1 or M2 is to correct anisotropic dose distribution at lattice peaks due to the planar spatial modulation of minibeams. For each minibeam-pLATTICE method, an optimization problem is formulated to optimize dose uniformity in target peaks and valleys, as well as dose-volume-histogram-based objectives. This optimization problem is solved using iterative convex relaxation and alternating direction method of multipliers (ADMM).
Results:
Three minibeam-pLATTICE methods are validated to demonstrate the feasibility of minibeam-pLATTICE for two clinical head-and-neck (HN), one abdominal, and one brain case. The advantages of this modality over conventional beam (CONV) pLATTICE are evaluated by comparing peak-to-valley dose ratio (PVDR) and dose delivered to organs at risk (OAR). All three minibeam-pLATTICE modalities achieved improved plan quality compared to CONV, with M2 yielding the best results. For instance, in one HN case, the following improvements were observed: PVDR increased to 3.73 (M2), compared to 3.27 (CONV), 3.72 (M0), and 3.49 (M1), while the mean dose to the mandible was reduced to 0.18 Gy (M2), compared to 0.33 Gy (CONV), 0.17 Gy (M0), and 0.14 Gy (M1).
Conclusions:
A novel minibeam-pLATTICE modality is proposed that can generate lattice dose patterns for small-to-medium target volumes, which are not achievable with conventional pLATTICE due to beam size limitations. Peak dose anisotropy due to 1D planar minibeam apertures is corrected through inverse treatment planning with alternating or multiple minibeam apertures per beam angle.
